Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Starrett

Showing results (251-260 of 296) with videos related to

Pageof 30
Sort By:
Nature Structural & Molecular Biology|December 20, 2016
Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3BKe Shi, Michael A Carpenter, Surajit Banerjee, et al.
Molecular Pharmacology|July 1, 1996
Effects of channel modulators on cloned large-conductance calcium-activated potassium channelsV K Gribkoff, J T Lum-Ragan, C G Boissard, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2002
The synthesis and characterization of BMS-204352 (MaxiPost) and related 3-fluorooxindoles as openers of maxi-K potassium channelsPiyasena Hewawasam, Valentin K Gribkoff, Yadagiri Pendri, et al.
Mbio|February 7, 2019
Polyomavirus T Antigen Induces <i>APOBEC3B</i> Expression Using an LXCXE-Dependent and TP53-Independent MechanismGabriel J Starrett, Artur A Serebrenik, Pieter A Roelofs, et al.
JCI Insight|April 3, 2025
TYRA-300, an FGFR3-selective inhibitor, promotes bone growth in two FGFR3-driven models of chondrodysplasiaJacqueline H Starrett, Clara Lemoine, Matthias Guillo, et al.
JCI Insight|February 8, 2022
Anti-PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLCEric Tu, Kelly McGlinchey, Jixin Wang, et al.
Nature Communications|October 10, 2018
Genetic and mechanistic basis for APOBEC3H alternative splicing, retrovirus restriction, and counteraction by HIV-1 proteaseDiako Ebrahimi, Christopher M Richards, Michael A Carpenter, et al.
Ambio|September 2, 2006
Building resilience and adaptation to manage Arctic changeF Stuart Chapin, Michael Hoel, Steven R Carpenter, et al.
Genome Medicine|March 20, 2020
Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinomaGabriel J Starrett, Manisha Thakuria, Tianqi Chen, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
(S)-N-[1-(4-cyclopropylmethyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]-3-(2-fluoro-phenyl)-acrylamide is a potent and efficacious KCNQ2 opener which inhibits induced hyperexcitability of rat hippocampal neuronsYong-Jin Wu, Christopher G Boissard, Jie Chen, et al.
Pageof 30

Showing results (251-260 of 296) with videos related to

Sort By:
Pageof 30
Nature Structural & Molecular Biology|December 20, 2016
Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3BKe Shi, Michael A Carpenter, Surajit Banerjee, et al.
Molecular Pharmacology|July 1, 1996
Effects of channel modulators on cloned large-conductance calcium-activated potassium channelsV K Gribkoff, J T Lum-Ragan, C G Boissard, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2002
The synthesis and characterization of BMS-204352 (MaxiPost) and related 3-fluorooxindoles as openers of maxi-K potassium channelsPiyasena Hewawasam, Valentin K Gribkoff, Yadagiri Pendri, et al.
Mbio|February 7, 2019
Polyomavirus T Antigen Induces <i>APOBEC3B</i> Expression Using an LXCXE-Dependent and TP53-Independent MechanismGabriel J Starrett, Artur A Serebrenik, Pieter A Roelofs, et al.
JCI Insight|April 3, 2025
TYRA-300, an FGFR3-selective inhibitor, promotes bone growth in two FGFR3-driven models of chondrodysplasiaJacqueline H Starrett, Clara Lemoine, Matthias Guillo, et al.
JCI Insight|February 8, 2022
Anti-PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLCEric Tu, Kelly McGlinchey, Jixin Wang, et al.
Nature Communications|October 10, 2018
Genetic and mechanistic basis for APOBEC3H alternative splicing, retrovirus restriction, and counteraction by HIV-1 proteaseDiako Ebrahimi, Christopher M Richards, Michael A Carpenter, et al.
Ambio|September 2, 2006
Building resilience and adaptation to manage Arctic changeF Stuart Chapin, Michael Hoel, Steven R Carpenter, et al.
Genome Medicine|March 20, 2020
Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinomaGabriel J Starrett, Manisha Thakuria, Tianqi Chen, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
(S)-N-[1-(4-cyclopropylmethyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]-3-(2-fluoro-phenyl)-acrylamide is a potent and efficacious KCNQ2 opener which inhibits induced hyperexcitability of rat hippocampal neuronsYong-Jin Wu, Christopher G Boissard, Jie Chen, et al.
Pageof 30